title: Bleomycin-induced Raynaud's phenomenon after single-dose exposure: risk factors and treatment with intravenous iloprost infusion.
authors.affiliation: University of Surrey, Guildford, United Kingdom.
authors.forename: Sophie E
authors.initials: SE
authors.lastname: McGrath
authors.forename: Andrew
authors.initials: A
authors.lastname: Webb
authors.forename: Karen
authors.initials: K
authors.lastname: Walker-Bone
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000627:therapeutic use*; D001761:Bleomycin / Q000008:administration & dosage*; D003606:Dacarbazine / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D005385:Fingers / Q000098:blood supply; D006689:Hodgkin Disease / Q000175:diagnosis / Q000000981:diagnostic imaging / Q000188:drug therapy*; D006801:Humans; D016285:Iloprost / Q000008:administration & dosage / Q000627:therapeutic use*; D007262:Infusions, Intravenous; D008297:Male; D008875:Middle Aged; D064847:Multimodal Imaging; D009336:Necrosis / Q000139:chemically induced; D049268:Positron-Emission Tomography; D011928:Raynaud Disease / Q000139:chemically induced* / Q000188:drug therapy*; D012074:Remission Induction; D012307:Risk Factors; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome; D014665:Vasodilator Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D014747:Vinblastine / Q000008:administration & dosage
chemical_list: D014665:Vasodilator Agents; D001761:Bleomycin; D014747:Vinblastine; D003606:Dacarbazine; D004317:Doxorubicin; D016285:Iloprost